OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M
Oct 31, 2023 16:15 ET
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities-Director BRANCACCIO JOHN P
Sep 28, 2023 06:15 ET
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
May 20, 2022 10:35 ET
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
May 19, 2022 11:14 ET
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
May 19, 2022 11:14 ET
OKYO Pharma | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Officer CERRONE GABRIELE M
May 18, 2022 13:38 ET
OKYO Pharma | 4: Statement of changes in beneficial ownership of securities
May 18, 2022 11:37 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Shah Keeren
May 16, 2022 17:53 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Simon Willy Jules
May 16, 2022 17:52 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities
May 16, 2022 17:47 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer JACOB GARY S
May 16, 2022 17:44 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Executive Chairman CERRONE GABRIELE M
May 16, 2022 17:41 ET
OKYO Pharma | 3: Initial statement of beneficial ownership of securities-Director Denoyer Bernard
May 16, 2022 17:37 ET
No Data
No Data